BIT:1BAYN - DE000BAY0017 - Common Stock
The current stock price of 1BAYN.MI is 28.11 EUR. In the past month the price decreased by -3.44%. In the past year, price increased by 2.03%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY.DE | ELI LILLY & CO | 46.54 | 605.64B | ||
1LLY.MI | ELI LILLY & CO | 46.53 | 605.55B | ||
ZEG.DE | ASTRAZENECA PLC | 18.34 | 427.71B | ||
1JNJ.MI | JOHNSON & JOHNSON | 17.86 | 365.97B | ||
JNJ.DE | JOHNSON & JOHNSON | 17.55 | 359.76B | ||
RHO.DE | ROCHE HOLDING AG-BR | 14.21 | 242.45B | ||
NOT.DE | NOVARTIS AG-REG | 14.48 | 208.61B | ||
NOV.DE | NOVO NORDISK A/S-B | 13.99 | 207.60B | ||
SNW.DE | SANOFI | 10.64 | 195.90B | ||
SAN.PA | SANOFI | 10.63 | 195.80B | ||
1SAN.MI | SANOFI | 10.61 | 195.46B | ||
6MK.DE | MERCK & CO. INC. | 10.91 | 178.84B |
Bayer AG engages in the business of life science fields of healthcare and nutrition. The company is headquartered in Leverkusen, Nordrhein-Westfalen and currently employs 89,556 full-time employees. The firm's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.
BAYER AG-REG
Kaiser-Wilhelm-Allee 1
Leverkusen NORDRHEIN-WESTFALEN DE
Employees: 89556
Phone: 49214301
The current stock price of 1BAYN.MI is 28.11 EUR. The price decreased by -1.07% in the last trading session.
The exchange symbol of BAYER AG-REG is 1BAYN and it is listed on the Euronext Milan exchange.
1BAYN.MI stock is listed on the Euronext Milan exchange.
28 analysts have analysed 1BAYN.MI and the average price target is 29.04 EUR. This implies a price increase of 3.32% is expected in the next year compared to the current price of 28.11. Check the BAYER AG-REG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BAYER AG-REG (1BAYN.MI) has a market capitalization of 27.62B EUR. This makes 1BAYN.MI a Large Cap stock.
BAYER AG-REG (1BAYN.MI) currently has 89556 employees.
BAYER AG-REG (1BAYN.MI) has a support level at 27.72 and a resistance level at 28.62. Check the full technical report for a detailed analysis of 1BAYN.MI support and resistance levels.
The Revenue of BAYER AG-REG (1BAYN.MI) is expected to decline by -1.14% in the next year. Check the estimates tab for more information on the 1BAYN.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BAYER AG-REG (1BAYN.MI) has a dividend yield of 0.38%. The yearly dividend amount is currently 0.13. Check the full fundamental report for a detailed analysis of 1BAYN.MI dividend history, reliability and sustainability.
BAYER AG-REG (1BAYN.MI) will report earnings on 2025-11-12.
The PE ratio for BAYER AG-REG (1BAYN.MI) is 5.61. This is based on the reported non-GAAP earnings per share of 5.01 and the current share price of 28.11 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1BAYN.MI.
ChartMill assigns a technical rating of 6 / 10 to 1BAYN.MI. When comparing the yearly performance of all stocks, 1BAYN.MI turns out to be only a medium performer in the overall market: it outperformed 54.18% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to 1BAYN.MI. 1BAYN.MI has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months 1BAYN.MI reported a non-GAAP Earnings per Share(EPS) of 5.01. The EPS decreased by -16.36% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -3.25% | ||
ROE | -11.25% | ||
Debt/Equity | 1.04 |
28 analysts have analysed 1BAYN.MI and the average price target is 29.04 EUR. This implies a price increase of 3.32% is expected in the next year compared to the current price of 28.11.
For the next year, analysts expect an EPS growth of -6.48% and a revenue growth -1.14% for 1BAYN.MI